Haddjeri N - Search Results

1

GnRH replacement rescues cognition in Down syndrome.

Manfredi-Lozano M, Leysen V, Adamo M, Paiva I, Rovera R, Pignat JM, Timzoura FE, Candlish M, Eddarkaoui S, Malone SA, Silva MSB, Trova S, Imbernon M, Decoster L, Cotellessa L, Tena-Sempere M, Claret M, Paoloni-Giacobino A, Plassard D, Paccou E, Vionnet N, Acierno J, Maceski AM, Lutti A, Pfrieger F, Rasika S, Santoni F, Boehm U, Ciofi P, Buée L, Haddjeri N, Boutillier AL, Kuhle J, Messina A, Draganski B, Giacobini P, Pitteloud N, Prevot V. Manfredi-Lozano M, et al. Among authors: haddjeri n. Science. 2022 Sep 2;377(6610):eabq4515. doi: 10.1126/science.abq4515. Epub 2022 Sep 2. Science. 2022. PMID: 36048943 Free PMC article.

2

Task- and Treatment Length-Dependent Effects of Vortioxetine on Scopolamine-Induced Cognitive Dysfunction and Hippocampal Extracellular Acetylcholine in Rats.

Pehrson AL, Hillhouse TM, Haddjeri N, Rovera R, Porter JH, Mørk A, Smagin G, Song D, Budac D, Cajina M, Sanchez C. Pehrson AL, et al. Among authors: haddjeri n. J Pharmacol Exp Ther. 2016 Sep;358(3):472-82. doi: 10.1124/jpet.116.233924. Epub 2016 Jul 11. J Pharmacol Exp Ther. 2016. PMID: 27402279 Free PMC article.

3

Asenapine modulates mood-related behaviors and 5-HT_1A/7 receptors-mediated neurotransmission.

Delcourte S, Abrial E, Etiévant A, Rovera R, Arnt J, Didriksen M, Haddjeri N. Delcourte S, et al. Among authors: haddjeri n. CNS Neurosci Ther. 2017 Jun;23(6):518-525. doi: 10.1111/cns.12698. Epub 2017 Apr 17. CNS Neurosci Ther. 2017. PMID: 28417559 Free PMC article.

4

Differential control of dopamine ascending pathways by serotonin2B receptor antagonists: New opportunities for the treatment of schizophrenia.

Devroye C, Cathala A, Haddjeri N, Rovera R, Vallée M, Drago F, Piazza PV, Spampinato U. Devroye C, et al. Among authors: haddjeri n. Neuropharmacology. 2016 Oct;109:59-68. doi: 10.1016/j.neuropharm.2016.05.024. Epub 2016 May 31. Neuropharmacology. 2016. PMID: 27260325

5

The novel atypical antipsychotic cariprazine demonstrates dopamine D₂ receptor-dependent partial agonist actions on rat mesencephalic dopamine neuronal activity.

Delcourte S, Ashby CR Jr, Rovera R, Kiss B, Adham N, Farkas B, Haddjeri N. Delcourte S, et al. Among authors: haddjeri n. CNS Neurosci Ther. 2018 Dec;24(12):1129-1139. doi: 10.1111/cns.12867. Epub 2018 May 4. CNS Neurosci Ther. 2018. PMID: 29729086 Free PMC article.

6

Genetic and pharmacological inactivation of astroglial connexin 43 differentially influences the acute response of antidepressant and anxiolytic drugs.

Portal B, Delcourte S, Rovera R, Lejards C, Bullich S, Malnou CE, Haddjeri N, Déglon N, Guiard BP. Portal B, et al. Among authors: haddjeri n. Acta Physiol (Oxf). 2020 May;229(1):e13440. doi: 10.1111/apha.13440. Epub 2020 Jan 16. Acta Physiol (Oxf). 2020. PMID: 31925934

7

The allosteric citalopram binding site differentially interferes with neuronal firing rate and SERT trafficking in serotonergic neurons.

Matthäus F, Haddjeri N, Sánchez C, Martí Y, Bahri S, Rovera R, Schloss P, Lau T. Matthäus F, et al. Among authors: haddjeri n. Eur Neuropsychopharmacol. 2016 Nov;26(11):1806-1817. doi: 10.1016/j.euroneuro.2016.09.001. Epub 2016 Sep 21. Eur Neuropsychopharmacol. 2016. PMID: 27665061

8

Opposite control of mesocortical and mesoaccumbal dopamine pathways by serotonin_2B receptor blockade: Involvement of medial prefrontal cortex serotonin_1A receptors.

Devroye C, Haddjeri N, Cathala A, Rovera R, Drago F, Piazza PV, Artigas F, Spampinato U. Devroye C, et al. Among authors: haddjeri n. Neuropharmacology. 2017 Jun;119:91-99. doi: 10.1016/j.neuropharm.2017.04.001. Epub 2017 Apr 5. Neuropharmacology. 2017. PMID: 28390892

9

In vivo effects of pardoprunox (SLV308), a partial D₂/D₃ receptor and 5-HT1A receptor agonist, on rat dopamine and serotonin neuronal activity.

Bétry C, Etiévant A, Lambás-Señas L, McCreary AC, Haddjeri N. Bétry C, et al. Among authors: haddjeri n. Synapse. 2011 Oct;65(10):1042-51. doi: 10.1002/syn.20936. Epub 2011 May 3. Synapse. 2011. PMID: 21446003

10

Pharmacological blockade of 5-HT7 receptors as a putative fast acting antidepressant strategy.

Mnie-Filali O, Faure C, Lambás-Señas L, El Mansari M, Belblidia H, Gondard E, Etiévant A, Scarna H, Didier A, Berod A, Blier P, Haddjeri N. Mnie-Filali O, et al. Among authors: haddjeri n. Neuropsychopharmacology. 2011 May;36(6):1275-88. doi: 10.1038/npp.2011.13. Epub 2011 Feb 16. Neuropsychopharmacology. 2011. PMID: 21326194 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

76 results

Search Page